Drug Shortage Report for LUTREPULSE
Report ID | 4514 |
Drug Identification Number | 02046202 |
Brand name | LUTREPULSE |
Common or Proper name | LUTREPULSE |
Company Name | FERRING INC |
Market Status | DORMANT |
Active Ingredient(s) | GONADORELIN ACETATE |
Strength(s) | 3.2MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS SUBCUTANEOUS |
Packaging size | 3 VIALS 3.2 MG LUTREPULSE FOR INJECTION |
ATC code | H01CA |
ATC description | HYPOTHALAMIC HORMONES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-03-28 |
Actual start date | 2017-03-28 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-03-19 |
Company comments | Alternative product is LUTREPULSE 0.8 mg. Please contact your healthcare professional. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2020-03-19 | French | Compare |
v10 | 2020-03-19 | English | Compare |
v9 | 2019-01-10 | French | Compare |
v8 | 2019-01-10 | English | Compare |
v7 | 2018-07-16 | French | Compare |
v6 | 2018-07-16 | English | Compare |
v5 | 2018-03-15 | French | Compare |
v4 | 2018-03-15 | English | Compare |
v3 | 2018-03-15 | English | Compare |
v2 | 2018-01-09 | English | Compare |
v1 | 2017-03-28 | English | Compare |
Showing 1 to 11 of 11